Since siRNA loss of LMTK2 perturbed axonal transport of both p35 and cdk5, we enquired whether LMTK2 levels might be altered in Alzheimer’s disease. This evidence concerns the gene LMTK2 and early-onset autosomal dominant Alzheimer disease.